Study Stopped
competing study started with same participants
Here's the Buzz: Evaluating Pediatric Post Op Pain and Nausea Following Tonsillectomy Surgery
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Tonsillectomy is one of the most common surgeries performed in the United States, with over half a million performed annually in children younger than 15 years of age. Postoperative pain is one of the most common clinical problems and may lead to poor intake, dehydration, and weight loss. Management of postoperative pain is often challenging and results in additional medical costs due to unplanned emergency room visits. Opioids such as codeine are commonly prescribed for pain control, however in 2013 the Food \& Drug Administration issued a black box warning for the use of codeine in post-tonsillectomy pediatric patients. The American Academy of Otolaryngology-Head and Neck Surgery recommends the use of acetaminophen and ibuprofen to successfully manage postoperative pain. With an extended recovery period, often longer than 7 days, alternative measures to reduce postoperative pain are needed. Honey has been proven to possess antibacterial and anti-inflammatory properties. This intervention will evaluate the effect of Tylenol, ibuprofen with honey on children's postoperative pain and nausea following tonsillectomy surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2021
CompletedFirst Posted
Study publicly available on registry
June 2, 2021
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedJuly 7, 2022
October 1, 2021
4 months
May 27, 2021
July 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Numeric value of post-operative pain measured by FACES pain scale
The post-operative pain is measured by the self-reported FACES pain scale. The range of scores is from 0-10. 0 (smiling face = no pain) and 10 (crying face) = worst pain ever. This scale is used by patients who are developmentally able, ages 5-9.
Post-operative day 0 to post-operative day 5.
Numeric value of post-operative pain measured by Visual Analog Scale (VAS) pain scale
The VAS uses a horizontal 10cm line with the extremes of "no pain at all" and "worst pain imaginable". The subject marks on the line their pain rating. Higher points indicate more severe or intense pain. This scale is used by patients who are developmentally able, ages 10-17.
Post-operative day 0 to post-operative day 5.
Numeric value of post-operative nausea measured by Baxter Animated Retching Faces (BARF) scale
Baxter Animated Retching Faces (BARF) scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more nausea).
Post-operative day 0 to post-operative day 5.
Secondary Outcomes (1)
Beliefs and receptiveness of patient families on pain management measured with the catastrophizing scale
Baseline to 6 weeks
Study Arms (2)
Standard of Care
ACTIVE COMPARATORThe first 50 participants will receive treatment as usual (alternating weight-based dosing of acetaminophen and ibuprofen with a PRN three-day supply of opioid analgesic).
Honey Intervention
EXPERIMENTALParticipants 51 - 100 will receive the standard of care treatment as usual plus 1 tsp of honey with every dose of acetaminophen.
Interventions
Participants 51 - 100 will receive the standard of care treatment as usual plus 1 tsp of honey with every dose of acetaminophen.
The first 50 participants will receive treatment as usual (alternating weight-based dosing of acetaminophen and ibuprofen with a PRN three-day supply of opioid analgesic).
Eligibility Criteria
You may qualify if:
- english speaking
- children ages 5-17 years
You may not qualify if:
- any child with a genetic syndrome or developmental disability
- allergies to honey
- non-english speaking families
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Patti Runyan, DNP
Monroe Carell Jr. Children's Hospital at Vanderbilt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Administrative Director
Study Record Dates
First Submitted
May 27, 2021
First Posted
June 2, 2021
Study Start
March 1, 2022
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
July 7, 2022
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share